
Piprafast T 1000mg/125mg Injection
Marketer
Invision Medi Sciences Pvt Ltd
Salt Composition
Piperacillin (1000mg) + Tazobactum (125mg)
Overview Piprafast T 1000mg/125mg Injection
T-Pipra 1000mg/125mg injection combines two antibiotics to combat diverse bacterial infections by eliminating microorganisms. Administered solely by healthcare providers, dosage and frequency are determined by a physician based on the infection's severity. Strict adherence to prescribed usage is crucial. Potential side effects may include gastrointestinal upset (nausea, vomiting, diarrhea), skin rash, and injection site reactions (pain, swelling, redness). Persistent or worsening side effects necessitate medical consultation. Prior to use, inform your physician of any antibiotic allergies, kidney or liver issues; adjustments to dosage or alternative medications may be necessary. Generally safe during pregnancy and lactation under medical guidance.
Uses of Piprafast T 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Piprafast T 1000mg/125mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Piprafast T 1000mg/125mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Piprafast T 1000mg/125mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Piprafast T 1000mg/125mg Injection works:
The injectable formulation Piprafast T (1000mg Piperacillin/125mg Tazobactum) combines the antibiotic Piperacillin with the beta-lactamase inhibitor Tazobactum. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counteracts bacterial resistance mechanisms, thereby augmenting Piperacillin's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of Piprafast T 1000mg/125mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Piprafast T (1000mg/125mg) is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Piprafast T (1000mg/125mg) presents no known breastfeeding contraindications. Research in humans indicates minimal drug transfer to breast milk, posing no apparent infant risk.
DrivingCONSULT YOUR DOCTOR
Driving ability while using Piprafast T 1000mg/125mg Injection is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with impaired kidney function, administration of Piprafast T 1000mg/125mg Injection requires careful monitoring. Dosage modification of Piprafast T 1000mg/125mg Injection may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Piprafast T 1000mg/125mg Injection in patients with liver impairment is likely safe. Preliminary evidence indicates dose modification may be unnecessary, but a physician's consultation is recommended.
What if you forget to take Piprafast T 1000mg/125mg Injection :
Should you inadvertently omit a dose of Piprafast T 1000mg/125mg Injection, seek medical advice.
Facts to Know About Piprafast T 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
